Evaluation of a Training Recommendation Strategy for Trail Runners. (TRAILWISE)

Finding the optimal training, i.e. the training that enables the athlete to achieve the best performance while preserving their physical and psychological integrity, is a multi-factorial issue.

Each individual's background and training capacity are very different, hence the need for personalised training. The availability of data combined with advances in Artificial Intelligence (data modelling and analysis sciences, big data, machine learning, deep learning, etc.) offer the opportunity to refine our understanding of training and adapt recommendations according to the runner's profile for a given objective (achieving a time over a distance, completing an event, etc.). The strategy that the investigators wish to evaluate as part of this trial could make it possible to recommend an optimal training load, as well as the distribution of intensities (as a percentage of the aerobic threshold, anaerobic threshold, VVO2max, etc). The two features are (i) the personalisation will be based on training history, the level of the runner, age and gender, and the runner can focus on training, and (ii) the strategy will be adaptive, i.e. the algorithm will update the training load in real time based on contextual data about the athlete (level of fatigue via heart rate variability, feedback on recent training sessions, feelings of stress).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

1209

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Have no contraindications to trail running (Fédération Française d'Athlétisme test procedures)
  • Have been trail running competitively for at least 1 year
  • In possession of an ITRA performance index
  • Intends to run at least one ITRA-indexed race in the second half of the follow-up period
  • Own a training watch, and intend to record all training sessions of more than 10 minutes in their shared database
  • Have freely given their written consent.

Exclusion Criteria:

  • Any person with chronic joint pathologies (e.g. recurrent sprains, patellar or ligament problems) or cardiac pathologies.
  • Any person with chronic or central neurological pathologies.
  • Any person deprived of their liberty or under legal protection (guardianship, curatorship, safeguard of justice, family habilitation).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: GEN: generic training plan group
The GEN group will follow a generic training plan that will be created from a platform that is both free and popular, offering training plans for trail-running (The Decathlon Pacer application).
Generic training plan that will be created from a platform that is both free and popular, offering training plans for trail-running (The Decathlon Pacer application).
Active Comparator: PERSO: non-adaptive personalized group
The PERSO group will follow a plan that takes into consideration the training history, in particular the number of hours per week over the previous two years; the runner's level; age and sex; time available for training; and access to mountainous terrain.
A training plan that takes into account the rider's training history, in particular the number of hours per week over the last two years, the rider's level, age and gender, the time available for training and access to mountainous terrain.
Experimental: PERSO-ADAPT group: adaptive personalized group
The PERSO-ADAPT group will include the same information as the PERSO group, but the training will also be adapted on a weekly basis according to the following feedback: state of fatigue assessed by questionnaire and heart rate variability; state of overtraining, assessed by questionnaire; degree of session completion).
A training plan that takes into account the rider's training history, in particular the number of hours per week over the last two years, the level, age and gender of the rider, the time available for training and access to mountainous terrain. Training will also be adapted on a weekly basis according to the following feedback: state of fatigue assessed by questionnaire and heart rate variability; state of overtraining, assessed by questionnaire; degree of completion of sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of the ITRA performance index
Time Frame: Month : 10
The main criterion for assessing the improvement in trail running performance will be the increase in the ITRA performance index of users following PERSO-ADAPT compared with the increase in the ITRA score of PERSO and GEN. The ITRA Performance Index (PI) is a tool that estimates a runner's level of performance. The performance index can be used to compare the level of different trail runners around the world and is built on a scale up to a maximum of 1000 points. The top of the scale corresponds to the theoretical best possible level.
Month : 10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of injuries
Time Frame: Weeks : 1 to 40
The number of injuries will be assessed on the basis of weekly injury records, with injury defined as any physical pain or disability resulting from running that prevents running for at least one day.
Weeks : 1 to 40
ROF (Rating-of-Fatigue Scale)
Time Frame: Weeks : 1 to 40
Fatigue will be assessed each week using the ROF (Rating-of-Fatigue Scale), validated in French. This scale from 0 to 10 with a pictogram gives an assessment that best reflects the perception of fatigue at that precise moment (from 0: not at all tired to 10: completely tired and exhausted).
Weeks : 1 to 40
RPE (Rating of Perceived Exertion)
Time Frame: Weeks : 1 to 40
RPE (Rating of Perceived Exertion) will be assessed each week using the Borg scale and a visual analogue scale (VAS). It comprises 11 levels of perceived exertion, ranging from 0 (no exertion) to 10 (maximum exertion).
Weeks : 1 to 40
Hooper questionnaire
Time Frame: Weeks : 1 to 40.
Overtraining will also be assessed using the Hooper questionnaire. The higher the score, the more likely the athlete is to be in a state of physical or mental overload.
Weeks : 1 to 40.
The '36-12' field test
Time Frame: Weeks : 6, 13, 20, 27, 34, 40.
Objective performance will be assessed by measuring critical speed, obtained using the '36-12' field test. This test, which can take the place of a training session, is carried out on a training track which is usual for the runner, and consists of: a run of 3600 metres, 30 minutes recovery time, then a run of 1200 metres. The time will be measured for each of the runs and the heart rate continuously recorded using the classic training heart rate monitor.
Weeks : 6, 13, 20, 27, 34, 40.
The 1200 test
Time Frame: Weeks : 6, 13, 20, 27, 34, 40.
Objective performance will be assessed through changes in the duration of the 1200 test: after a 10-minute low-intensity warm-up, the participant will have to run 1200 m on a track at an intensity considered to be "low", recording his speed and heart rate at the same time using his watch.
Weeks : 6, 13, 20, 27, 34, 40.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Leonard FEASSON, MD PhD, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

January 21, 2026

First Submitted That Met QC Criteria

January 21, 2026

First Posted (Actual)

January 28, 2026

Study Record Updates

Last Update Posted (Actual)

January 28, 2026

Last Update Submitted That Met QC Criteria

January 21, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endurance Training

Clinical Trials on Training recommendations GEN

Subscribe